CRISPR TECHNOLOGY MARKET ANALYSIS

Regional Analysis

Global CRISPR Technology Market: Regional Insights

Based on geography, the global CRISPR market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market over the forecast period owing to the increasing number of ongoing clinical trials and increasing research and development in this region. For instance, the first trial in the United States to test a CRISPR-made cancer therapy was launched in 2019 at the University of Pennsylvania. The study, funded in part by NCI (National Cancer Institute), is testing a type of immunotherapy in which patients own immune cells are genetically modified to better see and kill their cancer.

Asia Pacific is also expected to witness robust growth in the global CRISPR technology market owing to the increasing number of ongoing clinical trials in this region. For instance, in March 2021, Dublin-based ERS Genomics granted CRISPR-Cas9 patent to a Japanese biotech start-up, Setsuro Tech. Setsuro Tech is developing cell and animal models based on this technology, which in turn is expected to increase the adoption of CRISPR-Cas9 technology in the country leading to significant revenue generation in the near future.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa